Insomnia is the most common sleep disorder and one that virtually everyone will experience sometime in their lives. It can be irritating and temporary or long-lasting and debilitating. There is, ...
The National Institute for Health and Care Excellence (NICE) has recommended daridorexant (QUVIVIQ, Idorsia) as a new treatment option for long-term insomnia but underscored the importance of keeping ...
The insomnia treatment drug "Dayvigo" (dayvigo·lemborexant), which has drawn intense attention from the international sleep ...
The landscape of sleep medicine has evolved significantly, with insomnia emerging as a critical focus in healthcare. Modern understanding of this sleep disorder has revealed its complex nature and far ...
Sleep is something you may take for granted — until it becomes elusive. While an occasional sleepless night is nothing to worry about, chronic insomnia is a different story altogether. Affecting an ...
Instead of reaching for a pill, more people should switch to the recommended "first line" treatment for insomnia—the non-drug option. After exhaustive studies, the specially designed Cognitive ...
Psychologist Rafael Santandreu explains why trying to stay awake on purpose may help break the cycle of insomnia and fear.
A secondary analysis investigating the efficacy of a digital, interactive cognitive behavioral therapy program for insomnia (CBTi) demonstrated the positive impacts of the program for patients with ...
This article was reviewed by Daniel Z. Lieberman, MD. If you're struggling with depression, anxiety, insomnia or another issue affecting your mental health, you may have heard of the tricyclic ...
Only Slate Plus members can gift Slate stories. Become a member to share 10 free articles a month. Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, ...
Researchers are recommending full-scale human trials after an insomnia drug helped a man withdraw from his 16 drinks-a-day addiction. Minister for Education and Medical Research Hon Ben Carroll said ...